AstraZeneca PLC And Daiichi Pharmaceutical Co., Ltd. Sign $100M Nexium Deal

October 29, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, Oct 29 (Reuters) - Drugmakers AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) said on Friday they had reached an agreement to co-promote and supply heartburn treatment Nexium in Japan.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe

AstraZeneca Pharmaceuticals LP